Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

Anthropic is launching its own drug discovery programs for neglected diseases considered unprofitable by Big Pharma. Novartis CEO Vas Narasimhan says new AI models could cut development time from 12 years to 7-8 years and double success rates to 16 percent. Google Deepmind and OpenAI are also pushing into medicine with initiatives like Isomorphic Labs and ChatGPT Health.